Bexarotene: all 36 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- A Study of Bexarotene Combined With Radiotherapy in People With Mycosis FungoidesRecruitingNCT05296304Phase 1
- Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast CancerCompletedNCT03323658Phase 1Results posted
- Bexarotene Amyloid Treatment for Alzheimer's DiseaseCompletedNCT01782742Phase 2Results posted
- Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)CompletedNCT01007448Phase 4Results posted
- A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) ExpressionCompletedNCT00718770Early Phase 1Results posted
- Phase II Study of Bexarotene in Patients With Acute Myeloid LeukemiaTerminatedNCT00615784Phase 2Results posted
- Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaCompletedNCT00425477Phase 2Results posted
- BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00411632Phase 2Results posted
- Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell LymphomaCompletedNCT00255801Phase 2Results posted
- Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCLCompletedNCT00178841Phase 2Results posted
- A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung CancerTerminatedNCT00153842Phase 1/2Results posted
- An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients (0683-016)(TERMINATED)TerminatedNCT00127101Phase 1Results posted
- Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung CancerCompletedNCT00125359Phase 2Results posted
- Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung CancerCompletedNCT00050960Phase 3Results posted
- The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBCCompletedNCT04664829Phase 1
- A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy SubjectsCompletedNCT02061878Phase 1
- Phase I Study of CS-7017 and BexaroteneTerminatedNCT01504490Phase 1
- Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaCompletedNCT01134341Phase 1
- Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Advanced Cancers of the Aerodigestive TractCompletedNCT01116622Phase 1
- Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)CompletedNCT01001143Phase 1
- Preoperative Bexarotene Treatment for Cushing's DiseaseStatus unknownNCT00845351Phase 1/2
- Gemcitabine and Bexarotene in Treating Patients With Progressive or Refractory Stage IB, Stage II, Stage III, or Stage IV Cutaneous T-cell Non-Hodgkin LymphomaCompletedNCT00660231Phase 2
- Bexarotene and Fenretinide as Addition to Antipsychotic Treatment in Schizophrenia PatientsWithdrawnNCT00534898Phase 3
- Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00514293Phase 2
- Phase II Trial to Evaluate the Efficacy of Topical Bexarotene Gel in Patients With ParapsoriasisTerminatedNCT00322296Phase 2
- Study of Bexarotene in Patients With Acute Myeloid LeukemiaCompletedNCT00316030Phase 1
- Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell LymphomaCompletedNCT00306969Phase 1/2
- A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung CancerCompletedNCT00238628Phase 1/2
- Bexarotene Treatment in SchizophreniaStatus unknownNCT00141947Phase 3
- Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia AreataCompletedNCT00063076Phase 2/3
- Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis FungoidesTerminatedNCT00056056Phase 3
- Bexarotene in Preventing Breast Cancer in Women at Genetic RiskCompletedNCT00055991Phase 1
- Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung CancerCompletedNCT00050973Phase 3
- Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell LymphomaCompletedNCT00030849Phase 2
- Bexarotene in Treating Patients With Metastatic Breast CancerCompletedNCT00003752Phase 2
- A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00002212Phase 2